As the CXCR4 expression in the tumor was higher than in the normal tissues, the patient received a therapy combination of 8.2 GBq [90Y]Pentixather, a therapeutic CXCR4 ligand, and high-dose chemotherapy followed by autologous peripheral stem cell transplantation (University Hospital Würzburg). Here, CXCR4 is linked to neoplasm.